News

The RIVA System (Robotic Intravenous Automation) is a self-contained unit for filling IV syringes and bags, from Intelligent Hospital Systems (IH Systems). Mission Health System will use the

AMG 386 is an investigational peptibody that is designed to block angiogenesis by inhibiting angiopoietin-1 and -2 (Ang1 and Ang2). In the trial, overall survival in the 10mg/kg

IPI-926 has demonstrated the ability of IPI-926 to inhibit the Hedgehog pathway, further supporting the Phase 1b/2 study of IPI-926 in combination with Gemzar (gemcitabine) in patients with

SCOUT (Sibutramine Cardiovascular OUTcome Trial) study, 6-year study requested by European regulatory authorities as a post-marketing commitment to evaluate cardiovascular safety in high-risk patients, is the basis for

Sanofi Pasteur said that the contract supported by the HHS Biomedical Advanced Research and Development Authority (BARDA) affords rapid response and production of a strain-matched pandemic influenza vaccine

The transaction is expected to make MorphoSys the sole source of Sloning’s Slonomics technology, which improves the assembly and quality of protein libraries. MorphoSys said that by integrating

Last year Almac had added carbonyl reductase, transaminase, hydrolase, nitrilase, and nitrile hydratase enzyme screening kits to its biocatalysis business. Almac said that the investment will be used

IRIS is a manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, and a provider of personalized diagnostics testing services through

EPIC Bio will develop, manufacture and commercialise pandemic influenza vaccines and therapeutics. EPIC Bio plans to begin clinical manufacturing of a broad spectrum influenza vaccine candidate in 2011